Our Services
Lorem ipsum dolor sit amet consectetuer adipiscing elit sed diam nibh euismod tincidunt ut.
PrismGene® monoclonal antibody (mAb) production services include:
1. Recombinant protein and antibody expression
- Gene codon optimization
- Plasmid design and construction
- E. coli expression system
- Yeast expression system
- Baculovirus/ insect cell expression system
- Mammalian cells (transient or stable expressions)
- Stable single cell clone and protein production
- Fc fusion proteins
2. Monoclonal antibody (mAb) process development
- Single cell line cloning
- Fed-batch animal cell culture and fermentation process development
- Antibody purification process development and scale-up
- Antibody purification (Protein A, G, L affinity chromatography, IEX, SEC, HIC, HPLC)
- Upstream and downstream process integration and scale up
Multiple and flexible options of transient expression and stable expression technology are provided for different projects or different research phases.
PrismGene® provides the latest AI-assisted antibody discovery service and state-of-the-art antibody purification technology including affinity chromatography (AC), IMAC, ion exchange (IEX), gel filtration (SEC), hydrophobic interaction (HIC), and combination, process integration, optimization and scale-up.
- AI-assisted monoclonal antibody (mAb) discovery, bispecific antibody (bsAb) design and development
- Plasmid and expression vector design
- Multiple antibody expression platforms (E. coli, yeast, mammalian cells, hybridoma)
- Antibody analysis (BLI, SPR, KD, IC50, EC50) and functional characterization (ADCC, ADCP, CDC
- Fc fusion protein and nanobody (Nb) design and production
- Nonnatural amino acid-containing antibody design and production
PrismGene® provides multiple proprietary antibody expression platforms to meet various demands of different unique antibody. Multiple E. coli expression systems can obtain the protein in 1-2 weeks at low cost and high yield. Our yeast expression system can provide high-yield bulk eukaryotic proteins with low cost culture condition. Our mammalian cell expression systems (CHO, HEK293, Hybridoma) offer antibody with high-quality with full or better functions.
- Target & Epitope Prediction: AI tools trained on immunoinformatic data predict immunodominant regions on target proteins, identifying high-value epitopes and improving hit rates during early screening.
- Structure & Binding Prediction: Deep-learning models (such as AlphaFold and protein language models) predict 3D structures at atomic resolution—including difficult-to-model regions like the CDR H3 loop—to optimize antigen-antibody binding affinity and specificity.
- Generative Sequence Design: Instead of sorting through millions of library variants in the lab, generative AI models design novel antibody sequences in silico tailored to exact functional properties, stability, and humanized requirements.
- Affinity Maturation & Engineering: Protein language models and reinforcement learning suggest targeted mutations that boost binding strength while minimizing off-target interactions.
- Developability & Liability Assessment: Computational models screen candidate sequences early for aggregation risks, thermal stability, solubility, and high-concentration viscosity, cutting down late-stage failure rates.
- Advanced Modalities (BsAbs & ADCs): For complex formats like bispecific antibodies (bsAbs) and antibody-drug conjugates (ADCs), AI optimizes linker design, heterodimer pairing, drug-to-antibody ratios (DAR), and spatial geometry to balance potency and safety.
- Closed-Loop Discovery (AI + Wet-Lab): AI models generate candidate libraries, laboratory high-throughput platforms (such as automated expression and surface plasmon resonance) test them, and the resulting data loops back to retrain and refine the AI for subsequent rounds.
- Enzyme Assays: Measure the catalytic activity of enzymes (e.g., kinases, phosphatases, proteases, deacetylases) and test how compounds inhibit or stimulate them. Examples include kinase phosphorylation assays and HDAC/sirtuin assays.
- Immunoassays: Utilize specific antibody-antigen recognition to detect and quantify proteins, hormones, or viral antigens, Enzyme-Linked Immunosorbent Assay (ELISA).
- Ligand Binding and Protein-Protein Interaction Assays: Evaluate the affinity (KD), specificity, and binding kinetics between a protein and a small molecule, peptide, or macromolecular complex. Subtypes include radioligand binding and FRET (Fluorescence Resonance Energy Transfer) interaction assays.
- Viability and Cytotoxicity Assays: Assess whether a compound promotes cell survival, impairs metabolic health, or induces cell death. The methods include ATP-based luminescence, MTT, and resazurin reduction assays, etc.
- Cell Proliferation Assays: Measure the rate of cell division and growth over time using markers like BrdU incorporation or Ki-67 staining.
- Reporter Gene Assays: Quantify transcriptional activation or signal transduction by linking a promoter or pathway to a reporter enzyme, such as luciferase or Green Fluorescent Protein (GFP).
- Apoptosis and Cell Cycle Assays: Evaluate programmed cell death pathways and shifts in cell cycle phases via flow cytometry or fluorescent staining such as ADCC, ADCP, CDC.
- Functional and Phenotypic Assays: Monitor dynamic cellular events such as calcium flux, electrophysiology, sub-cellular localization, cell migration, and high-content imaging.
- Miniaturized Assay Formats: Uses high-density microtiter plates (96, 384, 1,536, or up to 3,456 wells) to reduce reagent volumes, lower costs, and speed up processing.
- Robotics & Liquid Handling: Automated workstations and robotic arms handle sample transfer, mixing, incubation, and plate movement with minimal human errors
- Acoustic Liquid Handling: Uses sound waves to eject nanoliter droplets without physical pipettes, preventing cross-contamination and increasing speed.
- Detection & Readout Systems:
Employs fluorescence, luminescence, time-resolved fluorescence resonance energy transfer (TR-FRET), fluorescence polarization (FP), and label-free mass spectrometry to measure biochemical or cellular responses.
- Target-Based Screening (TDD): Focuses on isolated biological targets (such as GPCRs, kinases, or specific enzymes) to find agonists, antagonists, or inhibitors.
- Phenotypic Screening: Evaluates whole cells or multi-cellular models to observe functional or behavioral changes without needing a pre-defined molecular target.
- Ultra-High-Throughput Screening (uHTS): Scales operations to test upwards of 100,000 to over 1,000,000 compounds per day using advanced industrial automation centers.
- Quality Control Metrics: Relies on statistical tools like the Z’-factor (scores between 0.5 and 1.0 indicate an excellent, robust assay) and signal-to-noise ratios to filter out false positives.
- Artificial Intelligence & Machine Learning: Modern HTS workflows integrate graph neural networks (GNNs), deep learning models, and automated image analysis to predict compound-target interactions, handle batch effect corrections, and prioritize hit compounds for hit-to-lead optimization.
Bioprocess Optimization and Scale-up
- Scale-Independent Parameter Optimization: Determining and locking down biological and chemical conditions that remain constant across scales, including temperature, pH, dissolved oxygen (DO) setpoints, media composition, and osmolality.
- Scale-Dependent Engineering & Hydrodynamic Studies: Managing physical parameters that shift as volume increases—such as mixing time, power input per volume (P/V), impeller tip speed, shear stress, and the volumetric oxygen transfer coefficient ((k_{L}a)).Designing agitation configurations, sparger designs, and reactor geometries to prevent nutrient, pH, or oxygen gradients.
- Heat Transfer & Cooling Design: Characterizing and managing metabolic heat generation to prevent local hot spots or thermal stress in large vessels.
- Computational Fluid Dynamics (CFD) & Modeling: Using virtual flow-field simulations to predict fluid behavior, residence time distribution, and shear profiles before building physical hardware. Integrating CFD with dynamic cellular reaction kinetic (CRK) models to evaluate how cells react to fluctuating environments inside industrial reactors.
- Scale-Down Modeling & Validation: Designing specialized small-scale systems (such as two-compartment bioreactors) that deliberately mimic the mixing and substrate gradients found in large industrial tanks to test stress responses cheaply.
- Seed Train Optimization: Designing robust multi-stage inoculum expansion pathways to maintain cell health, high viability, and genetic stability from the vial thaw to production-scale inoculation.
- Downstream Processing (DSP) Alignment: Refining harvest, centrifugation, filtration, and chromatography steps alongside upstream yields to ensure impurities, cell debris, and side products scale efficiently.
- Regulatory Compliance & Quality Attribute Mapping: Linking Critical Process Parameters (CPPs) to Critical Quality Attributes (CQAs) through systematic characterization studies to satisfy GMP (Good Manufacturing Practice) standards.
